These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 23042350)

  • 1. The ongoing battle against influenza: Drug-resistant influenza viruses: why fitness matters.
    Kelso A; Hurt AC
    Nat Med; 2012 Oct; 18(10):1470-1. PubMed ID: 23042350
    [No Abstract]   [Full Text] [Related]  

  • 2. Drugs: Lines of defence.
    Palmer R
    Nature; 2011 Dec; 480(7376):S9-10. PubMed ID: 22158299
    [No Abstract]   [Full Text] [Related]  

  • 3. Resistance and virulence mutations in patients with persistent infection by pandemic 2009 A/H1N1 influenza.
    Alonso M; Rodríguez-Sánchez B; Giannella M; Catalán P; Gayoso J; López Bernaldo de Quirós JC; Bouza E; García de Viedma D
    J Clin Virol; 2011 Feb; 50(2):114-8. PubMed ID: 21074490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Influenza A, will it keep on mutating?].
    Olea-Jiménez V; Mora-Ordóñez JM; Rodríguez-Díez A; Calbo-Torrecillas F
    Med Intensiva; 2012; 36(1):64. PubMed ID: 22197172
    [No Abstract]   [Full Text] [Related]  

  • 5. Swine flu outbreak. What role for antiviral drugs?
    Couzin-Frankel J
    Science; 2009 May; 324(5928):705. PubMed ID: 19423784
    [No Abstract]   [Full Text] [Related]  

  • 6. Influenza antiviral prescribing practices during the 2007-08 and 2008-09 influenza seasons in the setting of increased resistance to oseltamivir among circulating influenza viruses.
    Dharan NJ; Beekmann SE; Fiore A; Finelli L; Uyeki TM; Polgreen PM; Fry AM
    Antiviral Res; 2010 Nov; 88(2):182-6. PubMed ID: 20739002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oseltamivir-resistant pandemic (H1N1) 2009 virus, Mexico.
    Ramirez-Gonzalez JE; Gonzalez-Duran E; Alcantara-Perez P; Wong-Arambula C; Olivera-Diaz H; Cortez-Ortiz I; Barrera-Badillo G; Nguyen H; Gubareva L; Lopez-Martinez I; Díaz-Quiñonez JA; Lezana-Fernández MA; Gatell-Ramírez HL; Cordova Villalobos JA; Hernández-Avila M; Alpuche-Aranda C
    Emerg Infect Dis; 2011 Feb; 17(2):283-6. PubMed ID: 21291607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Current anti-influenza virus chemotherapy].
    Yoshioka D; Tokimatsu I; Ishii H; Kadota J
    Nihon Rinsho; 2010 Sep; 68(9):1679-84. PubMed ID: 20845747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Zanamivir-resistant influenza viruses with a novel neuraminidase mutation.
    Hurt AC; Holien JK; Parker M; Kelso A; Barr IG
    J Virol; 2009 Oct; 83(20):10366-73. PubMed ID: 19641000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emergence of Multidrug-Resistant Influenza A(H1N1)pdm09 Virus Variants in an Immunocompromised Child Treated With Oseltamivir and Zanamivir.
    Tamura D; DeBiasi RL; Okomo-Adhiambo M; Mishin VP; Campbell AP; Loechelt B; Wiedermann BL; Fry AM; Gubareva LV
    J Infect Dis; 2015 Oct; 212(8):1209-13. PubMed ID: 25943200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Naturally occurring oseltamivir resistance in influenza A].
    Madsen L; Nielsen A; Lundgren J
    Ugeskr Laeger; 2010 Aug; 172(32):2165-7. PubMed ID: 20696118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiviral drugs for influenza 2013-2014.
    Med Lett Drugs Ther; 2014 Jan; 56(1434):6-8. PubMed ID: 24457560
    [No Abstract]   [Full Text] [Related]  

  • 13. [Fatal pneumonitis due to oseltamivir-resistant new influenza A(H1N1) in the case of an intensive care patient].
    Aardema H; Tulleken JE; van den Biggelaar RJ; Wolters BA; de Jager CM; Boucher CA; Riezebos-Brilman A
    Ned Tijdschr Geneeskd; 2010; 154():A1634. PubMed ID: 20482913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A two-year survey of the oseltamivir-resistant influenza A(H1N1) virus in Yamagata, Japan and the clinical effectiveness of oseltamivir and zanamivir.
    Matsuzaki Y; Mizuta K; Aoki Y; Suto A; Abiko C; Sanjoh K; Sugawara K; Takashita E; Itagaki T; Katsushima Y; Ujike M; Obuchi M; Odagiri T; Tashiro M
    Virol J; 2010 Mar; 7():53. PubMed ID: 20202225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Presence of oseltamivir-resistant pandemic A/H1N1 minor variants before drug therapy with subsequent selection and transmission.
    Ghedin E; Holmes EC; DePasse JV; Pinilla LT; Fitch A; Hamelin ME; Papenburg J; Boivin G
    J Infect Dis; 2012 Nov; 206(10):1504-11. PubMed ID: 22966122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Virology. Helping the resistance.
    Holmes EC
    Science; 2010 Jun; 328(5983):1243-4. PubMed ID: 20522766
    [No Abstract]   [Full Text] [Related]  

  • 17. Development of oseltamivir and zanamivir resistance in influenza A(H1N1)pdm09 virus, Denmark, 2014.
    Trebbien R; Pedersen SS; Vorborg K; Franck KT; Fischer TK
    Euro Surveill; 2017 Jan; 22(3):. PubMed ID: 28128091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emerging oseltamivir resistance in seasonal and pandemic influenza A/H1N1.
    Renaud C; Kuypers J; Englund JA
    J Clin Virol; 2011 Oct; 52(2):70-8. PubMed ID: 21684202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emergence of oseltamivir resistance: control and management of influenza before, during and after the pandemic.
    Dixit R; Khandaker G; Ilgoutz S; Rashid H; Booy R
    Infect Disord Drug Targets; 2013 Feb; 13(1):34-45. PubMed ID: 23675925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. First isolation of a oseltamivir-resistant influenza A (H1N1) strain in Argentina.
    Cané A; Casanueva E; Iolster T; Sticco N; Richards L; Sosa P; Pontoriero A; Avaro M; Zcech A; Carabajal E; Campos A; Baumeister E; Diez MA; Rojas M; Rivarola MR
    Pediatr Infect Dis J; 2010 Apr; 29(4):384. PubMed ID: 20351531
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.